Trump Tariffs Ignite Global Business Evolution
U.S. Telehealth and Retail Lab Testing Market Size And Forecast
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
What is Telehealth and Retail Lab Testing?
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
What's inside a TRI industry report?
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
U.S. Telehealth and Retail Lab Testing Market Overview
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Telemedicine and virtual treatment have grown by leaps and bounds in recent years. This trend has fuelled the development of telehealth and research facility testing in the United States, as well as made medical treatment more accessible to a huge number of people worldwide. Previously, traditional clinical consideration models anticipated that the majority of tasks, such as laboratory tests, would necessitate patients visiting a specialist’s office or a crisis centre. This frequently meant long waits, heightened strain, and large financial outlays. Patients, on the other hand, now have access to healthcare services at their leisure and on their terms, thanks to advances in telemedicine and virtual care.
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
U.S. Telehealth and Retail Lab Testing Market: Segmentation Analysis
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
U.S. Telehealth and Retail Lab Testing Market, By Sample Type
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
U.S. Telehealth and Retail Lab Testing Market, By Test Type
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
U.S. Telehealth and Retail Lab Testing Market, By End-user
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
U.S. Telehealth and Retail Lab Testing Market, Mode of Payment
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Key Players
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Key Developments
Report Scope
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Error in rephrasing: [WinError 10061] No connection could be made because the target machine actively refused it
Research Methodology of The Research Insights:
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support
Frequently Asked Questions
What is the projected market size & growth rate of the U.S. Telehealth and Retail Lab Testing Market?
What are the key driving factors for the growth of the U.S. Telehealth and Retail Lab Testing Market?
What are the top players operating in the U.S. Telehealth and Retail Lab Testing Market?
What segments are covered in the U.S. Telehealth and Retail Lab Testing Market?
How can I get a sample report/company profiles for the U.S. Telehealth and Retail Lab Testing Market?
Frequently Asked Questions About This Report
1What is the projected market size & growth rate of the U.S. Telehealth and Retail Lab Testing Market?
U.S. Telehealth and Retail Lab Testing Market was valued at USD 927.11 Million in 2021 and is projected to reach USD 3,120.99 Million by 2030, growing at a CAGR of 15.28% from 2023 to 2030.
2What are the key driving factors for the growth of the U.S. Telehealth and Retail Lab Testing Market?
The direct-to-consumer testing is a remarkable extension to the traditional healthcare model for consumers desiring information regarding their disease risk and health situation, ancestry, and their body’s probable response to certain prescriptions depending on their genotype. The benefits of direct-to-consumer testing are driving and enticing the telehealth and retail lab testing market.
3What are the top players operating in the U.S. Telehealth and Retail Lab Testing Market?
The major players in the market are Laboratory Corporation of America, 23andMe, Any Lab Test Now, Color Health, Inc., DirectLabs, LLC., Everlywell, EasyDNA, MyMedLab, Medichecks.com Ltd., and Quest Diagnostics.
4What segments are covered in the U.S. Telehealth and Retail Lab Testing Market?
The U.S. Telehealth and Retail Lab Testing Market is segmented on the basis of Sample Type, Test Type, End-user, and Mode of Payment
5How can I get a sample report/company profiles for the U.S. Telehealth and Retail Lab Testing Market?
The sample report for the U.S. Telehealth and Retail Lab Testing Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS2 RESEARCH METHODOLOGY
2.1 REPORT SCOPE
2.2 DATA MINING
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.2.3 SUBJECT MATTER EXPERT ADVICE
2.2.4 QUALITY CHECK
2.2.5 FINAL REVIEW
2.3 DATA TRIANGULATION
2.4 BOTTOM-UP APPROACH
2.5 TOP-DOWN APPROACH
2.6 RESEARCH FLOW
2.7 DATA SOURCES3 EXECUTIVE SUMMARY
3.1 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET OVERVIEW
3.2 U.S. TELEHEALTH AND RETAIL LAB TESTING ECOLOGY MAPPING
3.3 U.S. TELEHEALTH AND RETAIL LAB TESTING ABSOLUTE MARKET OPPORTUNITY
3.4 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET ATTRACTIVENESS, BY END USER
3.5 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY TEST TYPE (USD MILLION)
3.6 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY END-USER (USD MILLION)
3.7 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY SAMPLE TYPE (USD MILLION)
3.8 FUTURE MARKET OPPORTUNITIES4 MARKET OUTLOOK
4.1 US TELEHEALTH AND RETAIL LAB TESTING MARKET EVOLUTION
4.2 US TELEHEALTH AND RETAIL LAB TESTING MARKET OUTLOOK
4.3 DRIVERS
4.3.1 GROWING PREFERENCE FOR AT-HOME OR DTC TESTING
4.3.2 RISE OF TELEMEDICINE AND VIRTUAL CARE
4.4 RESTRAINTS
4.4.1 MISINTERPRETATION OF TEST RESULTS
4.4.2 TESTING WITHOUT REGARD TO CLINICAL HISTORY MAY HAMPER DIAGNOSIS
4.5 OPPORTUNITIES
4.5.1 COVID-19 CRISIS HAS CREATED SEVERAL OPPORTUNITIES IN THE MARKET
4.5.2 INCREASE IN EMPHASIS ON PATIENT-DRIVEN HEALTHCARE
4.6 IMPACT OF COVID – 19 ON THE US TELEHEALTH AND RETAIL LAB TESTING MARKET
4.7 PORTER’S FIVE FORCES ANALYSIS
4.7.1 THREAT OF NEW ENTRANTS
4.7.2 THREAT OF SUBSTITUTES
4.7.3 BARGAINING POWER OF SUPPLIERS
4.7.4 BARGAINING POWER OF BUYERS
4.7.5 INTENSITY OF COMPETITIVE RIVALRY
4.8 VALUE CHAIN ANALYSIS
4.9 PRICING ANALYSIS
4.10 MACROECONOMIC ANALYSIS
4.11 TELEHEALTH BEHAVIORAL HEALTH ANALYSIS
4.12 TRENDS FOR TRADITIONAL HEALTHCARE AND TELEHEALTH
4.13 U.S. INITIATIVES, REGULATION & POLICIES FOR THE TELEHEALTH AND RETAIL LAB TESTING MARKET5 MARKET, BY TEST TYPE
5.1 OVERVIEW
5.2 ROUTINE TESTING
5.3 BLOOD CELL COUNT
5.4 CHOLESTEROL LEVEL TESTING
5.5 DIABETES TESTING
5.6 HIV TESTING
5.7 PREGNANCY TESTING
5.8 OTHERS6 MARKET, BY END-USER
6.1 OVERVIEW
6.2 HOSPITALS
6.3 SPECIALTY LABS
6.4 DIAGNOSTIC CENTERS
6.5 OTHERS7 MARKET, BY SAMPLE TYPE
7.1 OVERVIEW
7.2 BLOOD
7.3 SALIVA
7.4 URINE
7.5 OTHERS8 COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING ANALYSIS
8.3 COMPANY REGIONAL FOOTPRINT
8.4 COMPANY INDUSTRY FOOTPRINT
8.5 ACE MATRIX
8.5.1 ACTIVE
8.5.2 CUTTING EDGE
8.5.3 EMERGING
8.5.4 INNOVATORS9 COMPANY PROFILES
9.1 LABORATORY CORPORATION OF AMERICA
9.1.1 COMPANY OVERVIEW
9.1.2 COMPANY INSIGHTS
9.1.1 SEGMENT BREAKDOWN
9.1.2 PRODUCT BENCHMARKING
9.1.3 SWOT ANALYSIS
9.1.4 WINNING IMPERATIVES
9.1.5 CURRENT FOCUS & STRATEGIES
9.1.6 THREAT FROM COMPETITION9.2 23ANDME
9.2.1 COMPANY OVERVIEW
9.2.2 COMPANY INSIGHTS
9.2.3 SEGMENT BREAKDOWN
9.2.4 PRODUCT BENCHMARKING
9.2.5 KEY DEVELOPMENTS
9.2.6 SWOT ANALYSIS
9.2.7 WINNING IMPERATIVES
9.2.8 CURRENT FOCUS & STRATEGIES
9.2.9 THREAT FROM COMPETITION9.3 ANY LAB TEST NOW
9.3.1 COMPANY OVERVIEW
9.3.2 COMPANY INSIGHTS
9.3.3 PRODUCT BENCHMARKING
9.3.4 SWOT ANALYSIS
9.3.5 WINNING IMPERATIVES
9.3.6 CURRENT FOCUS & STRATEGIES
9.3.7 THREAT FROM COMPETITION9.4 COLOR HEALTH, INC.
9.4.1 COMPANY OVERVIEW
9.4.2 COMPANY INSIGHTS
9.4.3 PRODUCT BENCHMARKING9.5 DIRECT LABORATORY SERVICES
9.5.1 COMPANY OVERVIEW
9.5.2 COMPANY INSIGHTS
9.5.3 PRODUCT BENCHMARKING9.6 EASYDNA
9.6.1 COMPANY OVERVIEW
9.6.2 COMPANY INSIGHTS
9.6.3 PRODUCT BENCHMARKING9.7 EVERLYWELL
9.7.1 COMPANY OVERVIEW
9.7.2 PRODUCT BENCHMARKING9.8 MYMEDLAB
9.8.1 COMPANY OVERVIEW
9.8.2 COMPANY INSIGHTS
9.8.3 PRODUCT BENCHMARKING9.9 GAMECHANGER
9.9.1 COMPANY OVERVIEW
9.9.2 COMPANY INSIGHTS
9.9.3 PRODUCT BENCHMARKING9.1 CURA
9.10.1 COMPANY OVERVIEW
9.10.2 COMPANY INSIGHTS
9.10.3 PRODUCT BENCHMARKINGLIST OF TABLES
TABLE 1 GDP GROWTH (ANNUAL PERCENTAGE) OUTLOOK FOR THE US
TABLE 2 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY TEST TYPE, 2021 - 2030 (USD MILLION)
TABLE 3 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY END-USER, 2021 - 2030 (USD MILLION)
TABLE 4 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY SAMPLE TYPE, 2021 - 2030 (USD MILLION)
TABLE 5 COMPANY MARKET RANKING ANALYSIS
TABLE 6 COMPANY REGIONAL FOOTPRINT
TABLE 7 COMPANY INDUSTRY FOOTPRINT
TABLE 8 LABORATORY CORPORATION OF AMERICA: PRODUCT BENCHMARKING
TABLE 9 LABORATORY CORPORATION OF AMERICA: WINNING IMPERATIVES
TABLE 10 23ANDME: PRODUCT BENCHMARKING
TABLE 11 23ANDME: WINNING IMPERATIVES
TABLE 12 ANY LAB TEST NOW: PRODUCT BENCHMARKING
TABLE 13 ANY LAB TEST: WINNING IMPERATIVES
TABLE 14 COLOR HEALTH, INC.: PRODUCT BENCHMARKING
TABLE 15 DIRECT LABORATORY SERVICES: PRODUCT BENCHMARKING
TABLE 16 EASYDNA: PRODUCT BENCHMARKING
TABLE 17 EVERLYWELL: PRODUCT BENCHMARKING
TABLE 18 MYMEDLAB: PRODUCT BENCHMARKING
TABLE 19 GAMECHANGER PRODUCTS: PRODUCT BENCHMARKING
TABLE 20 CURA: PRODUCT BENCHMARKINGLIST OF FIGURES
FIGURE 1 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET SEGMENTATION
FIGURE 2 RESEARCH TIMELINES
FIGURE 3 DATA TRIANGULATION
FIGURE 4 MARKET RESEARCH FLOW
FIGURE 5 DATA SOURCES
FIGURE 6 U.S. TELEHEALTH AND RETAIL LAB TESTING ECOLOGY MAPPING
FIGURE 7 U.S. TELEHEALTH AND RETAIL LAB TESTING ABSOLUTE MARKET OPPORTUNITY
FIGURE 8 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY TEST TYPE (USD MILLION)
FIGURE 9 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY END-USER (USD MILLION)
FIGURE 10 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY SAMPLE TYPE (USD MILLION)
FIGURE 11 FUTURE MARKET OPPORTUNITIES
FIGURE 12 PORTER’S FIVE FORCES ANALYSIS
FIGURE 13 VALUE CHAIN ANALYSIS
FIGURE 14 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY TEST TYPE
FIGURE 15 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY END-USER
FIGURE 16 U.S. TELEHEALTH AND RETAIL LAB TESTING MARKET, BY SAMPLE TYPE
FIGURE 17 ACE MATRIX
FIGURE 18 LABORATORY CORPORATION OF AMERICA: COMPANY INSIGHT
FIGURE 19 LABORATORY CORPORATION OF AMERICA: BREAKDOWN
FIGURE 20 LABORATORY CORPORATION OF AMERICA: SWOT ANALYSIS
FIGURE 21 23ANDME: COMPANY INSIGHT
FIGURE 22 23ANDME: BREAKDOWN
FIGURE 23 23ANDME: KEY DEVELOPMENTS
FIGURE 24 23ANDME: SWOT ANALYSIS
FIGURE 25 ANY LAB TEST NOW: COMPANY INSIGHT
FIGURE 26 ANY LAB TEST: SWOT ANALYSIS
FIGURE 27 COLOR HEALTH, INC.: COMPANY INSIGHT
FIGURE 28 DIRECT LABORATORY SERVICES: COMPANY INSIGHT
FIGURE 29 EASYDNA: COMPANY INSIGHT
FIGURE 30 EVERLYWELL: COMPANY INSIGHT
FIGURE 31 MYMEDLAB: COMPANY INSIGHT
FIGURE 32 GAMECHANGER PRODUCTS: COMPANY INSIGHT
FIGURE 33 CURA: COMPANY INSIGHTThe research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures of the market/sub-segments in the current scenario as well as for the forecast period. After estimating the markets and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.
1.1 DATA MINING
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the industry and their Drivetrain, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
1.2 SECONDARY RESEARCH
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at TRI have access to some of the most diversified and extensive paid databases, which give us the most accurate data/information on markets Customers, and pricing. Mentioned below is a detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data sources depending on the need.
1.3 PRIMARY RESEARCH
In the primary research process, in-depth primary interviews are conducted with the CXOs to understand the market share, customer base, pricing strategies, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXOs of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both the supply and demand side are interviewed to obtain qualitative and quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (Corporates), industry consultants, and C-Component executives of major companies, are conducted to obtain critical qualitative and quantitative information pertaining to the market, as well as to assess the prospects for market growth during the forecast period. Detailed information on these primary respondents is mentioned below.
1.4 FORCASTING TECHNIQUES
We at Markstats Research Insights Private Limited follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques as mentioned below.
The free sample includes data points such as market estimates, growth rate, size of the largest region and segment of the market.
Send me a FREE SampleHow will you benefit from our consulting services?
Check Now
Related Reports
US +1 312-313-8080
India +91-89564-46619
Copyright © All rights reserved
